Login to your account

Username *
Password *
Remember Me

Blog With Right Sidebar

Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease

The authors have reviewed the current literature on airway inflammation and remodeling in smoking-related chronic obstructive pulmonary disease (COPD). Detailed data on airway remodeling in COPD are especially sparse and how these changes lead to decline in lung function is not well understood.

Small airway fibrosis and obliteration are likely to be the main contributors to physiological airway dysfunction and occur earlier than any subsequent development of emphysema. One potential mechanism contributing to small airway fibrosis/obliteration and change in extracellular matrix is epithelial–mesenchymal transition. When associated with angiogenesis (so-called epithelial–mesenchymal transition type 3) it may well also be the link with the development of cancer, which is closely associated with COPD, predominantly in large airways.

The authors have focused on our recent publications in these areas. Further investigations teasing out these mechanisms will help improve our understanding of key airway disease processes in COPD, which may have major therapeutic implications.

ATS Publishes Clinical Practice Guidelines On Sleep Apnea And Driving

The American Thoracic Society has released new clinical practice guidelines on sleep apnea, sleepiness, and driving risk on non-commercial drivers. The new guidelines, which are an update of a 1994 ATS statement on this topic, appear in the June 1, 2013 American Journal of Respiratory and Critical Care Medicine. "Up to 20 percent of crashes that occur on monotonous roads can be attributed to sleepiness, and the most common medical cause of excessive daytime sleepiness is obstructive sleep apnea (OSA)," said Kingman P... (Source: Health News from Medical News Today)

Azithromycin May Prolong Time to Rehospitalization in COPDAzithromycin May Prolong Time to Rehospitalization in COPD

For patients with chronic obstructive pulmonary disease (COPD) hospitalized for a respiratory cause, azithromycin might prolong time to respiratory-related and all-cause rehospitalization. Medscape Medical News (Source: Medscape Today Headlines)

Diuretic treatment linked to COPD steroid efficacy

Research shows that patients with chronic obstructive pulmonary disease benefit the most from the addition of an inhaled corticosteroid to their bronchodilator therapy if they are receiving diuretics or show significant bronchodilator reversibility. (Source: MedWire News - Respiratory)

Novavax produces vaccine for newly emerging Middle East virus

Novavax has produced a vaccine candidate to protect against the emerging Middle East respiratory syndrome coronavirus (MERS-CoV), the company announced yesterday. (Source: Pharmaceutical Technology)

Search